Zobrazeno 1 - 10
of 21
pro vyhledávání: '"O. Goloshchapov"'
Autor:
P.V. Kozhokar, Alexey B. Chukhlovin, Alexander A. Shcherbakov, A.D. Kulagin, Oksana V. Stanevich, R.V. Klementeva, A.N. Shvetsov, Biological Agency, Saint Petersburg, Russia, Ivan S. Moiseev, M.V. Gorchakova, Sergey Sidorenko, V.V. Gostev, Maxim A. Kucher, E.V. Semenova, L.S. Zubarovskaya, O. Goloshchapov, M.A. Suvorova, S.V. Bondarenko, O.V. Paina
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:17-27
In recent years, the important role of disturbances in the intestinal microbiota and its possible correction in children with oncological and autoimmune diseases has been established. The aim of the article is to review the literature data on the iss
Autor:
Maxim A. Kucher, Maria A. Suvorova, Ludmila S. Zubarovskaya, P.V. Kozhokar, Alexander A. Shcherbakov, Oksana V. Stanevich, Elena V. Babenko, Ruslana V. Klementeva, O. Goloshchapov, O.V. Paina, Ivan S. Moiseev, Alexander N. Shvetsov, Alexander D. Kulagin, Margarita V. Gorchakova, Evgeny A. Bakin, Sergey N. Bondarenko
Publikováno v:
Cellular Therapy and Transplantation. 10:69-78
Autor:
Oksana V. Stanevich, E.A. Bakin, Sergey N. Bondarenko, O. Goloshchapov, Alexey B. Chukhlovin, Ivan S. Moiseev, A. D. Kulagin, L.S. Zubarovskaya, Ruslana V. Klementeva, Maxim A. Kucher, A.N. Shvetsov, M.A. Suvorova, Alexander A. Shcherbakov
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 43-54 (2020)
Was to evaluate clinical efficacy, adverse events and changes in the gut microbiome after fecal microbiota transplantation (FMT) in patients with gastrointestinal (GI) form of graft-versus-host disease (GVHD).The prospective single-center study in R.
Autor:
E.A. Bakin, Sergey Sidorenko, Dmitry E. Polev, Maria O. Goloshchapova, Vladimir Gostev, Oleg S. Glotov, Ruslana V. Klementeva, Ludmila S. Zubarovskaya, Oksana V. Stanevich, Anastasia Yu. Lobenskaya, Alexei B. Chukhlovin, Maxim A. Kucher, Ivan S. Moiseev, Maria A. Suvorova, Alexander Suvorov, Yury A. Eismont, O. Goloshchapov
Publikováno v:
Cellular Therapy and Transplantation. 9:47-59
Summary Fecal microbiota transplantation (FMT), as any other medical procedure, requires standardization of results, approaches, monitoring of its dynamics and microbiota engraftment evaluation. The aim of the present study was to compare efficiency
Autor:
Aleksandr A. Shcherbakov, Alexander N. Shvetsov, Maria O. Goloshchapova, Boris V. Afanasyev, O. Goloshchapov, Ruslana V. Klementeva, Vadim E. Karev, Natalia D. Ventslovayte
Publikováno v:
Cellular Therapy and Transplantation. 8:57-61
Autor:
M. Popova, I. Nikolaev, N. N. Klimko, L.S. Zubarovskaya, A. Frolova, Yu. A. Rogacheva, T. Bogomolova, A. Gevorgian, Boris V. Afanasyev, A. Volkova, TA Bykova, O.V. Paina, O. Goloshchapov, K.A. Ekushov, Ivan S. Moiseev, Olga N. Pinegina, Inna V. Markova, M. D. Vladovskaya, A. Shvetcov, S. M. Ignatyeva
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 18:53-58
Invasive fungal disease due to Candida spp. – Invasive candidiasis/candidaemia, is a life-threatening complication in immunosuppressed patients. The publications on epidemiology of invasive candidiasis (IC) in children after hematopoietic stem cell
Autor:
Vasiliy I. Trofimov, Elena I. Darskaya, Ivan S. Moiseev, A. Volkova, Nataliya B. Mikhaylova, Valeriy N. Marchenko, Tatiana S. Razumovskaya, O. Goloshchapov, Elena V. Morozova, Tatiana A. Rudakova, Anna G. Smirnova, Boris V. Afanasyev, Julia D. Rabik, Sergey N. Bondarenko, Egor A. Kulagin, Tatiana I. Shchemelinina, Ruf D. Skvortsova, Victoria G. Timchik, I. Nikolaev
Publikováno v:
Cellular Therapy and Transplantation. 8:26-37
Autor:
Shcherbakov A, Moiseev I, I Kazantsev, Suvorova M, L.S. Zubarovskaya, A. Shvetcov, O. Goloshchapov, M. Kucher, Afanasyev B, Klementeva R
Publikováno v:
Transplantation Research Journal. 3
This short communication accompanies our presentation at the 43rd Annual meeting of the European Society for Blood and Marrow Transplantation held in Marseille, France, 26-29 March 2017. Also it briefly summaries some recent advances in fecal microbi
Autor:
O. Goloshchapov, A.N. Shvetsov, M.A. Kucher, Alexey B. Chukhlovin, M.A. Suvorova, A.A. Scherbakov, Ruslana V. Klementeva, B.V. Afanas’ev, I.S. Moiseev
Publikováno v:
Infekcionnye bolezni. 15:65-74
Autor:
Vera Pawlowsky-Glahn, Vladimir A. Veselovsky, Vadim M. Govorun, Juan José Egozcue, Elena S. Kostryukova, Alexander I. Manolov, Ivan S. Moiseev, Margarita V. Gorchakova, Alexander A. Shcherbakov, Alexey B. Chukhlovin, Vladimir Gostev, Evgenii I. Olekhnovich, Alexander N. Shvetcov, Maxim A. Kucher, Alexander V. Pavlenko, Elvira D. Gumbatova, O. Goloshchapov, Elena N. Ilina, Evgeny A. Bakin, Ruslana V. Klementeva, Boris V. Afanasyev, Sergey Sidorenko, Dmitry E. Fedorov, Ksenia M. Klimina, Maria A. Suvorova
Publikováno v:
BMC Microbiology
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
BMC Microbiology, 2019, vol. 19, art. núm. 312
Articles publicats (D-IMA)
DUGiDocs – Universitat de Girona
instname
BMC Microbiology, Vol 19, Iss 1, Pp 1-13 (2019)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
BMC Microbiology, 2019, vol. 19, art. núm. 312
Articles publicats (D-IMA)
DUGiDocs – Universitat de Girona
instname
Background Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8f37a7b35334534b986848b0029be2